Abstract Five isolates harboring qepA were studied by polymerase chain reaction (PCR) amplification and relevant methods. One was determined to be a novel qepA3 from Enterobacter aerogenes, and four involved three qepA1 and one qepA2 determinants from Escherichia coli; the qepA3 changed five amino acids. These results characterized genetic structures A, B, C, D, and E.
Introduction
In the past, the most common mechanisms of resistance to quinolones for pathogenic bacteria were the genetic mutations in chromosomal encoding DNA gyrase and/or topoisomerase IV, 1, 2 and changes in the expression of porin proteins for efflux pumps such as qepA and oqxAB were also common quinolone resistance mechanisms. 3 Recently, a new plasmid mediated quinolone efflux pump, qepA1, was identified in three Escherichia coli isolates from Japan and Belgium. 4, 5 The qepA1 gene was associated with the rmtB gene, which conferred high level resistance to aminoglycosides. 6, 7 In the course of study, we discovered a novel qepA3 variant, three qepA1, and one qepA2 determinants in an isolate of Enterobacter aerogenes and four isolates of E. coli, and reported features of the qepA genes.
Materials and methods Strains
Ninety-eight consecutive non-duplicate isolates including E. coli (43 isolates), E. aerogenes (36 isolates), and Enterobacter cloacae (19 isolates) were collected and detected for qepA from specimens in our laboratories between January 2008 and June 2010. Five of 98 isolates carried the qepA gene by polymerase chain reaction (PCR) amplification and sequencing. The numbers EC2468, EC2751, EC3762, EC3319, and EA3201 represented these four isolates of E. coli and one isolate of E. aerogenes, respectively. All isolates were identified with Vitek GNI þ cards (bioMérieux, Lyon, France), and species identification was confirmed by sequence analysis of the16 S-23 S rRNA gene intergenic spacer region.
Conjugation experiments
Conjugation experiments were performed with five isolates as donors and azide-resistant E. coli J53 as recipient strain by filter mating. Transconjugants were selected on LB agar plates supplemented with sodium azide (150 mg/mL) and ciprofloxacin (0.25 mg/mL). From the transconjugants, plasmid DNA was extracted, and the DNA sequences adjacent to qepA were determined with primers, starting from both sides of the qepA. The minimum inhibitory concentrations (MICs) for donors, transconjugants, and recipient were also measured with MICs of quinolone and several blactam antibiotics (Table 1) .
PCR amplification, gene mapping, restriction with HindIII, and southern hybridization of HindIII digestion with qepA probe specific To study the plasmids carrying qepA and surrounding genes from five isolates, DNA was extracted from the plasmids (Axygen kit, California, USA) and separated by 0.6% agarose gel electrophoresis (60 V, 90 minutes) (Promega, Madison, USA). The gels were cut and plasmid DNA fragments of different sizes were extracted. These plasmid DNA fragments served as templates for PCR amplification of qepA and surrounding genes, then sequencing, where the positions of these gene plasmids were determined. The size of the plasmid DNAs was estimated. 8 The amplified products were also purified and digested with HindIII. The resulting fragments were ligated into HindIII-digested plasmid pBKCMV, and transformed into E. coli DH10B, which was used for determining quinolone resistance genes. Meanwhile, the resulting fragments were electrophoresed separately through 0.6% agarose gel, and were transferred onto a positively charged nylon membrane (Boehringer, Mannheim, Germany) with capillary transfer. Then, they were subjected to southern hybridization of HindIII digestion with qepA probe specific. The digoxigenin DNA labeling and detection kits (Boehringer Mannheim) were utilized.
Results

Susceptibility testing
The MICs of antimicrobial agents such as ciprofloxacin, levofloxacin, ofloxacin, nalidixic acid, and others (Table 1) were determined by the dilution methods according to the Clinical and Laboratory Standards Institute guidelines. MIC values of 83 isolates (39 E. coli, 29 E. aerogenes, and 15 E. cloacae) showed ciprofloxacin ! 0.25 mg/mL, levofloxacin ! 0.25 mg/mL, ofloxacin ! 0.5 mg/mL, and nalidixic acid ! 16 mg/mL; MIC values of four isolates of E. coli (EC2468, EC2751, EC3762, and EC3319) and one isolate of E. aerogenes (EA3201) are listed in Table 1 . The susceptibility testing results showed that MICs of quinolones, several blactam antibiotics, and amikacin for five isolates and the transconjugants were generally much higher than those of E. coli J53 (Table 1) . Especially, MICs of the transconjugant from isolate EA3201 (EA-ECJ53) at ciprofloxacin, levofloxacin, and ofloxacin are much higher than those of the transconjugants from isolates EC2468, EC2751, EC3762, and EC3319 (EC-ECJ53) (Table 1) . Simultaneously, the ratios of MICs for the transconjugant and recipient isolate E. coli J53 at ciprofloxacin, levofloxacin, and ofloxacin are also much higher in 80-fold, 80-fold, and 160-fold levels, respectively.
Genetic structure for qepA and surrounding genes
With PCR amplification and sequencing using primers, we sequenced the plasmids of five isolates in lengths. The qepA3 variant located on ca.102 kb-length plasmid EA3201, and other qepAs located on ca.124 kb-, 145 kb-, 131 kb-, and 111 kb-length plasmids from isolates EC2468, EC2751, EC3762, and EC3319, respectively. By PCR amplification, the recombinant plasmids were determined to have no other quinolone resistant genes. Gene assembling and analyzing showed that the qepA3, qepA1, and qepA2 determinants from isolates EA3201, EC2468, EC2751, EC3762, and EC3319 were flanked or linked by full-or partial-length tnpA, intI1, rmtB, and bla TEM-1 genes ( Figure 1 ); there were five structures A, B, C, D, and E in these isolates.
Meanwhile, the restriction sites with HindIII digestion at aagctt are shown in Figure 1 and achieved recombinant plasmids pEA3201, pEC2468, pEC2751, pEC3762, and pEC3319 for ca. 6.2 kb-length plasmid fragments harboring qepA and surrounding genes. Southern hybridization of HindIII digestion with qepA probe specific indicated that these qepAs also located on ca. 6.2 kb-length recombinant plasmids.
Putative amino acid variations for qepA genes in the isolates
Fourteen-transmembrane (TMS) motifs were analyzed. Three mutations of amino acids in the QepA3 located on 8-, 10-and 12-TMS motifs, but two mutations were out of TMS motifs. The putative amino acid point mutations might be associated with the quinolone resistance in the isolates. Five amino acid mutations were also observed for the novel qepA3 variant from isolate EA3201, and they were different Figure 1 . Partial genetic environments of the qepA3, qepA1, and qepA2 determinants for plasmids EA3201, EC2468, EC2751, EC3762, and EC3319. The reading frames are shown as arrows with the arrowhead indicating the direction of transcription. It identified structures for the black arrows with opposite direction representing qepA and tnpA genes (ISCR3C transposon determinant). Restriction sites at aagctt with HindIII are indicated, pEA3201, pEC2468, pEC2751, pEC3762, and EC3319 are recombinant plasmids. (A) the genetic structure A harboring a novel qepA3 variant gene; (B), (C), and (D), the genetic structure B, C, and D, respectively, harbouring qepA1 genes; (E) the genetic structure E harboring qepA2 gene.
Features of a novel qepA3 variant 3 + MODEL at sites Ala (A) 235 Glu (E), Pro (P) 274 Leu (L), Trp (W) 318 Cys (C), Met (M) 372 Lys (K), and Ala (A) 445 Thr (T), when compared with the qepA1 genes from isolates EC2468, EC2751, and EC3762; the novel qepA3 variant gene was deposited in GenBank as accession number JQ064560.
Promoter expression for bla TEM-1 , rmtB and novel qepA3 gene in genetic struction A
There are six genes in the 8663 bp PCR amplicon of genetic structure A, including bla TEM-1 , rmtB, intI1, novel qepA3, and different-length tnpA genes. The sites of transcriptional promoter for bla TEM-1 , rmtB, and novel qepA3 genes are indicated as þ1, also shown as À10 and À35 regions.
Discussion
This study determined the lower incidences (5/89) of qepA gene among 89 nonrepetitive E. coli, E. aerogenes, and E. cloacae of patient origins and characterized the positive isolates. The presence of qepA genes was investigated, and showed characteristics of qepA genes in the five isolates. By analysis of susceptibility testing, the ratios of MICs for the transconjugant from isolate EA3201 and recipient isolate E. coli J53 at ciprofloxacin, levofloxacin, and ofloxacin were highest in 80-fold, 80-fold, and 160-fold levels, respectively, much higher than those for the transconjugants from isolates EC2468, EC2751, EC3762, and EC3319 and recipient isolate E. coli J53. The ratios were also far higher than those of a reference report. 8 We guessed it might be relevant to genetic mutation, especially genetic mutation on 8-, 10-and 12-TMS motifs. Therefore, we confirmed the novel qepA3 could increase the MICs of quinolones at much higher levels; these results also reminded us of the qepA dissemination mediating with plasmids.
We determined a novel qepA variant from isolate EA3201 located on an approximately 102-kb-long plasmid, and other qepAs located on approximately 124-kb-, 145-kb-, 131-kb-, and 111-kb-long plasmids from four other isolates. These qepA genes were flanked or linked with full-or partial-length tnpA, intI1, rmtB, and bla TEM-1 genes, and five different genetic structures A, B, C, D, and E were discovered in isolates EA2301, EC2468, EC2751, EC3762, and EC3319, respectively, by gene mapping (Figure 1) . However, the common structures were identical with qepA and tnpA genes (ISCR3C transposon determinants) showing opposite direction in the five structures (Figure 1) . Except for the qepA1 from isolate EC2468 in structure B, the novel qepA3 and the other qepA genes (qepA1 and qepA2 determinants) were linked with rmtB genes as well in structures A, C, D, and E (Figure 1 ). The isolate EA3201 was first isolated from a patient's sputum in an intensive care unit ward, and was subsequently discovered in the patient's blood as well. The patient was a farmer, and was once wounded by a farm implement in the field before coming to be hospitalized. We also determined the identific qepA3 variant from soil bacteria. The isolates EC2751, EC3762, and EC3319 were also from farmers, but we had no evidence to determine if the qepA genes came from soil or poultry and livestock. The findings supported a hypothesis that the uptake of qepA from soil bacteria was by rmtBproducing E. coli or E. aerogenes. Meanwhile, A qepA was also found in an rmtB producing E. coli strain isolated in a Belgian hospital, suggesting a probable worldwide dissemination of qepA accompanied by rmtB, which had been identified in Asia and Europe. 9, 10 Hence, active surveillance of qepA-harboring Gram-negative bacteria in soil or animals might reveal a greater prevalence of such kinds of multidrug-resistant microbes.
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